{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:46:48Z","timestamp":1789987608655,"version":"4.0.1"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501429"],"award-info":[{"award-number":["81501429"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["S2012040007488"],"award-info":[{"award-number":["S2012040007488"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jconrel.2022.01.050","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T21:30:12Z","timestamp":1643923812000},"page":"551-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A potential delivery system based on cholera toxin: A macromolecule carrier with multiple activities"],"prefix":"10.1016","volume":"343","author":[{"given":"Xianying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huantao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.01.050_bb0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.farmac.2005.04.015","article-title":"PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties","volume":"60","author":"Bersani","year":"2005","journal-title":"Farmaco"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2020.04.001","article-title":"Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes","volume":"323","author":"Chatzikleanthous","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","article-title":"Liposomes used as a vaccine adjuvant-delivery system: from basics to clinical immunization","volume":"303","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0020","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1002\/anie.201900135","article-title":"Microenvironment-induced in situ self-assembly of polymer-peptide conjugates that attack solid tumors deeply","volume":"58","author":"Cong","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2017.08.014","article-title":"Ferritin nanocage with intrinsically disordered proteins and affibody: a platform for tumor targeting with extended pharmacokinetics","volume":"267","author":"Lee","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biomaterials.2018.11.012","article-title":"Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery","volume":"192","author":"Banskota","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.actbio.2017.05.053","article-title":"Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs","volume":"58","author":"Wei","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2014.06.003","article-title":"A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins","volume":"188","author":"Shen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbrc.2021.08.021","article-title":"Engineering of an EpCAM-targeting cyclic peptide to improve the EpCAM-mediated cellular internalization and tumor accumulation of a peptide-fused antibody","volume":"573","author":"Park","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.toxicon.2019.04.005","article-title":"Specific targeting of a pore-forming toxin (listeriolysin O) to LHRH-positive cancer cells using LHRH targeting peptide","volume":"164","author":"Kheirandish","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0055","doi-asserted-by":"crossref","first-page":"27528","DOI":"10.1073\/pnas.2006186117","article-title":"Selective tumor antigen vaccine delivery to human CD169(+) antigen-presenting cells using ganglioside-liposomes","volume":"117","author":"Affandi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biopha.2019.108750","article-title":"Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment","volume":"113","author":"AlQahtani","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addr.2021.113884","article-title":"Drug delivery carriers with therapeutic functions","volume":"176","author":"Cai","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/acs.biomac.9b01351","article-title":"Antigen delivery to antigen-presenting cells for adaptive immune response by self-assembled anionic polysaccharide Nanogel vaccines","volume":"21","author":"Miura","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2017.12.013","article-title":"Bacillus spore-based oral carriers loading curcumin for the therapy of colon cancer","volume":"271","author":"Yin","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0080","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1080\/21645515.2018.1504155","article-title":"Oral cholera vaccines and their impact on the global burden of disease","volume":"15","author":"Wierzba","year":"2019","journal-title":"Hum. Vacc. Immunother."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tibs.2010.02.003","article-title":"Structure, biological functions and applications of the AB(5) toxins","volume":"35","author":"Beddoe","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ceb.2016.03.019","article-title":"Intracellular trafficking of bacterial toxins","volume":"41","author":"Williams","year":"2016","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0095","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1091\/mbc.E15-01-0014","article-title":"The nucleotide exchange factors Grp170 and Sil1 induce cholera toxin release from BiP to enable retrotranslocation","volume":"26","author":"Williams","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0100","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(17)30559-7","article-title":"Cholera","volume":"390","author":"Clemens","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coph.2018.03.015","article-title":"ADP-ribosylating enterotoxins as vaccine adjuvants","volume":"41","author":"Lycke","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0110","first-page":"179","article-title":"Cholera toxin: a paradigm of a multifunctional protein","volume":"133","author":"Bharati","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/vaccines3030579","article-title":"Cholera toxin subunit B as adjuvant-an accelerator in protective immunity and a break in autoimmunity","volume":"3","author":"Stratmann","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0120","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3390\/toxins2071612","article-title":"A paradigm switch from deadly to desirable","volume":"2","author":"Odumosu","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jconrel.2011.11.028","article-title":"Clinical impact of serum proteins on drug delivery","volume":"161","author":"Kratz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0130","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.biopha.2019.01.012","article-title":"Inhibition of mouse RM-1 prostate cancer and B16F10 melanoma by the fusion protein of HSP65 & STEAP1 (186-193)","volume":"111","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0135","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jconrel.2020.08.065","article-title":"Temperature-triggered micellization of interferon alpha-diblock copolypeptide conjugate with enhanced stability and pharmacology","volume":"328","author":"Wang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2016.04.047","article-title":"The corn smut-made cholera oral vaccine is thermostable and induces long-lasting immunity in mouse","volume":"234","author":"Monreal-Escalante","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trim.2012.06.004","article-title":"Prolonged survival time of allografts by the oral administration of RDP58 linked to the cholera toxin B subunit","volume":"27","author":"Yu","year":"2012","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0150","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijbiomac.2020.02.215","article-title":"B subunit of cholera toxin fused with VP7 from GCRV (grass carp reovirus) was expressed in E. coli and folds into an active protein","volume":"151","author":"Zhao","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0155","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/carcin\/bgu325","article-title":"Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer","volume":"36","author":"Doulberis","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41467-018-04814-4","article-title":"Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients","volume":"9","author":"Ji","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13010036","article-title":"Harnessing the membrane translocation properties of AB toxins for therapeutic applications","volume":"13","author":"Piot","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/mi.2016.95","article-title":"Oral administration of a recombinant cholera toxin B subunit promotes mucosal healing in the colon","volume":"10","author":"Baldauf","year":"2017","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2036.2009.04185.x","article-title":"Clinical trial: the safety and short-term efficacy of recombinant cholera toxin B subunit in the treatment of active Crohn\u2019s disease","volume":"31","author":"Stal","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0180","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jviromet.2010.11.023","article-title":"Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit","volume":"171","author":"Hu","year":"2011","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0185","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1399-3038.2011.01205.x","article-title":"Oral tolerance induction by partially hydrolyzed whey protein in mice is associated with enhanced numbers of Foxp3(+) regulatory T-cells in the mesenteric lymph nodes","volume":"22","author":"van Esch","year":"2011","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","article-title":"Mucosal vaccines: strategies and challenges","volume":"217","author":"Li","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0195","first-page":"9","article-title":"Nasal route for vaccine and drug delivery: features and current opportunities","volume":"572","author":"Mato","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0200","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1286-4579(01)01460-5","article-title":"IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms","volume":"3","author":"Macpherson","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0205","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3109\/08820130903124770","article-title":"Immunotherapy of autoimmune diabetes by nasal Administration of Tandem Glutamic Acid Decarboxylase 65 peptides","volume":"38","author":"Wang","year":"2009","journal-title":"Immunol. Investig."},{"issue":"11","key":"10.1016\/j.jconrel.2022.01.050_bb0210","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.vaccine.2021.02.002","article-title":"Co-delivery of PSMA antigen epitope and mGM-CSF with a cholera toxin-like chimeric protein suppressed prostate tumor growth via activating dendritic cells and promoting CTL responses","volume":"39","author":"Lin","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0215","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.4049\/jimmunol.176.5.2749","article-title":"Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin","volume":"176","author":"Luci","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.micpath.2015.08.013","article-title":"B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2\/6-VLP specific antibody responses and induce a Th17-like response after intrarectal immunization","volume":"89","author":"Thiam","year":"2015","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0225","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/JVI.80.4.1752-1761.2006","article-title":"Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection","volume":"80","author":"Parez","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0230","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/JVI.80.8.3823-3832.2006","article-title":"Intrarectal immunization with rotavirus 2\/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice","volume":"80","author":"Agnello","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0235","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","article-title":"Cholera toxin structure, gene regulation and pathophysiological and immunological aspects","volume":"65","author":"Sanchez","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0240","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.vetmic.2017.01.020","article-title":"Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit Al (CTAI) fusion protein with poly gamma-glutamate\/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes","volume":"201","author":"Chowdhury","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0245","first-page":"249","article-title":"Liposomes targeted to deliver antisecretory agents to jejunal mucosa, Canadian journal of veterinary research =","volume":"56","author":"Uwiera","year":"1992","journal-title":"Rev. Canad. Rech. Vet."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cne.902940203","article-title":"Cholera toxin B-gold, a retrograde tracer that can be used in light and electron microscopic immunocytochemical studies","volume":"294","author":"Llewellyn-Smith","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mabi.201900017","article-title":"Efficient cholera toxin B subunit-based nanoparticles with MRI capability for drug delivery to the brain following intranasal administration","volume":"19","author":"Chen","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0260","doi-asserted-by":"crossref","first-page":"15635","DOI":"10.1039\/C5NR04361A","article-title":"A novel fluorescent retrograde neural tracer: cholera toxin B conjugated carbon dots","volume":"7","author":"Zhou","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0265","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.actbio.2019.11.045","article-title":"Red fluorescent AuNDs with conjugation of cholera toxin subunit B (CTB) for extended-distance retro-nerve transporting and long-time neural tracing","volume":"102","author":"Zhao","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0270(00)00298-3","article-title":"Tracer-toxins: cholera toxin B-saporin as a model","volume":"103","author":"Llewellyn-Smith","year":"2000","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0275","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cne.10894","article-title":"Crossed and uncrossed retinal projections to the hamster circadian system","volume":"466","author":"Muscat","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00429-009-0212-x","article-title":"The efficacy of the fluorescent conjugates of cholera toxin subunit B for multiple retrograde tract tracing in the central nervous system","volume":"213","author":"Conte","year":"2009","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0165-0270(88)90039-8","article-title":"A simple and rapid method for the production of cholera B-chain coupled to horseradish peroxidase for neuronal tracing","volume":"22","author":"McIlhinney","year":"1988","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnins.2018.00887","article-title":"Strategies for targeted delivery to the peripheral nerve","volume":"12","author":"Langert","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0295","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2008.05.040","article-title":"Nasal administration of cholera toxin B subunit-nerve growth factor improves the space learning and memory abilities in beta-amyloid protein(25-35)-induced amnesic mice","volume":"155","author":"Zhang","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0300","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.vaccine.2012.04.047","article-title":"Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks","volume":"30","author":"Miyata","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0305","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jconrel.2020.03.027","article-title":"An in vitro and in vivo study of the brain-targeting effects of an epidermal growth factor-functionalized cholera toxin-like chimeric protein","volume":"322","author":"He","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0270(99)00055-2","article-title":"A new method for simultaneous demonstration of anterograde and retrograde connections in the brain: co-injections of biotinylated dextran amine and the beta subunit of cholera toxin","volume":"91","author":"Coolen","year":"1999","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/adhm.201700709","article-title":"Cholera toxin subunit B enabled multifunctional glioma-targeted drug delivery","volume":"6","author":"Guan","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0320","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneumeth.2016.09.003","article-title":"A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells","volume":"273","author":"Porras","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0325","first-page":"661","article-title":"Uptake and intracellular fate of cholera toxin subunit b-modified mesoporous silica nanoparticle-supported lipid bilayers (aka protocells) in motoneurons, Nanomed.-Nanotechnol","volume":"14","author":"Porras","year":"2018","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0330","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2017.08.066","article-title":"Sleep-inducing effect of substance P-cholera toxin a subunit in mice","volume":"659","author":"Zielinski","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0335","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-10-73","article-title":"Characteristics of dorsal root ganglia neurons sensitive to substance P","volume":"10","author":"Moraes","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0340","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jpain.2010.05.007","article-title":"Central sensitization in the trigeminal nucleus Caudalis produced by a conjugate of substance P and the a subunit of cholera toxin","volume":"11","author":"Caudle","year":"2010","journal-title":"J. Pain"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0345","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1039\/C8BM01285G","article-title":"Polymeric micro- and nanoparticles for immune modulation","volume":"7","author":"Ben-Akiva","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0355","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(02)00734-X","article-title":"Induction of cytotoxic T lymphocyte responses by cholera toxin-treated bone marrow-derived dendritic cells","volume":"21","author":"Jang","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0360","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1051\/vetres:2007020","article-title":"Cholera toxin promotes the generation of semi-mature porcine monocyte-derived dendritic cells that are unable to stimulate T cells","volume":"38","author":"Bimczok","year":"2007","journal-title":"Vet. Res."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0365","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0370","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/IAI.71.4.1740-1747.2003","article-title":"Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development","volume":"71","author":"Eriksson","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0375","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1521-0391.2013.00314.x","article-title":"Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine","volume":"22","author":"Orson","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0385","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/S0264-410X(00)00487-4","article-title":"The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity","volume":"19","author":"Lycke","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0390","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.intimp.2014.07.035","article-title":"Prolonged pretreatment of mice with cholera toxin, but not isoproterenol, alleviates acute lethal systemic inflammatory response","volume":"23","author":"Wang","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0395","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2012.05.087","article-title":"cAMP prevents TNF-induced apoptosis through inhibiting DISC complex formation in rat hepatocytes","volume":"423","author":"Bhattacharjee","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0400","doi-asserted-by":"crossref","DOI":"10.1111\/all.14284","article-title":"CCL2 mitigates cyclic AMP-suppressed Th2 immune response in human dendritic cells","volume":"75","author":"Kim","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0405","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20062129","article-title":"Cyclic adenosine monophosphate is a key component of regulatory T cell mediated suppression","volume":"204","author":"Bopp","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0410","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7554\/eLife.49416","article-title":"Inhibition of IRF4 in dendritic cells by PRR-independent and -dependent signals inhibit Th2 and promote Th17 responses","volume":"9","author":"Lee","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0415","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1371\/journal.pone.0178114","article-title":"Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion","volume":"12","author":"Silva-Vilches","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0420","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cellsig.2010.11.018","article-title":"Cyclic AMP-mediated immune regulation - overview of mechanisms of action in T cells","volume":"23","author":"Mosenden","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0425","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0430","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.vaccine.2013.05.028","article-title":"Transcutaneous immunization of healthy volunteers with an attenuated listeria monocytogenes vaccine strain and cholera toxin adjuvant","volume":"31","author":"Eypper","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2012.01.013","article-title":"A combined approach of vesicle formulations and microneedle arrays for transcutaneous immunization against hepatitis B virus","volume":"46","author":"Hirschberg","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0440","first-page":"571","article-title":"Effects of the adjuvant cholera toxin on dendritic cells: stimulatory and inhibitory signals that result in the amplification of immune responses","volume":"291","author":"Cristina","year":"2002","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0445","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1016\/j.vaccine.2007.05.041","article-title":"Therapeutic dendritic cell vaccination with ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours","volume":"25","author":"Chandy","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.imlet.2017.05.004","article-title":"Immunomodulatory activity of recombinant alpha-gliadin conjugated to cholera toxin in DQ8 transgenic mice","volume":"187","author":"Rossi","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0455","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1016\/j.vaccine.2010.06.068","article-title":"Conjugation of HPV16 E7 to cholera toxin enhances the HPV-specific T-cell recall responses to pulsed dendritic cells in vitro in women with cervical dysplasia","volume":"28","author":"Nurkkala","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0460","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJMp048006","article-title":"Nasal vaccination, Escherichia coli enterotoxin, and Bell\u2019s palsy","volume":"350","author":"Couch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0465","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0923-2494(98)80144-2","article-title":"The mechanism of cholera toxin adjuvanticity","volume":"148","author":"Lycke","year":"1997","journal-title":"Res. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0470","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/S0264-410X(00)00532-6","article-title":"Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate","volume":"19","author":"Shen","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0475","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1016\/j.vaccine.2008.03.096","article-title":"Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin","volume":"26","author":"Boberg","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0480","doi-asserted-by":"crossref","first-page":"8451","DOI":"10.1016\/j.vaccine.2011.07.077","article-title":"Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function","volume":"29","author":"Odumosu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0485","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/eji.201343633","article-title":"Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice","volume":"43","author":"Presa","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0490","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/toxins13080543","article-title":"Cholera toxin as a probe for membrane biology","volume":"13","author":"Kenworthy","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0495","first-page":"531","article-title":"Intranasal immunization using CTA1-DD as a mucosal adjuvant for an inactivated influenza vaccine","volume":"32","author":"Fan","year":"2019","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0500","first-page":"7","article-title":"Prevention of influenza virus infection and transmission by intranasal administration of a porous maltodextrin nanoparticle-formulated vaccine","volume":"582","author":"Le","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pep.2017.08.010","article-title":"CTA1: purified and display onto gram-positive enhancer matrix (GEM) particles as mucosal adjuvant","volume":"141","author":"Zhang","year":"2018","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0510","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/nat.2017.0717","article-title":"Antitumor response by endoplasmic reticulum-targeting DNA vaccine is improved by adding a KDEL retention signal","volume":"28","author":"Perez-Trujillo","year":"2018","journal-title":"Nucl. Acid Therapeut."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0515","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jdermsci.2009.04.008","article-title":"HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity","volume":"55","author":"Yin","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0520","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cei.12487","article-title":"Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model","volume":"180","author":"Kap","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fimmu.2017.01133","article-title":"A novel approach to reinstating tolerance in experimental autoimmune myasthenia gravis using targeted fusion protein, mCTA1-T146","volume":"8","author":"Consonni","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0530","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.jmb.2018.05.043","article-title":"Structural and biochemical study of the mono-ADP-Ribosyltransferase domain of SdeA, a Ubiquitylating\/Deubiquitylating enzyme from legionella pneumophila","volume":"430","author":"Kim","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0535","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.4049\/jimmunol.177.5.3045","article-title":"A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking","volume":"177","author":"Hagiwara","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0540","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1016\/j.vaccine.2009.07.071","article-title":"Oral MucoRice expressing double-mutant cholera toxin a and B subunits induces toxin-specific neutralising immunity","volume":"27","author":"Yuki","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0545","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.vaccine.2016.03.002","article-title":"Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae","volume":"34","author":"Lebens","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0550","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1016\/j.vaccine.2018.07.073","article-title":"Preclinical immunogenicity and protective efficacy of an oral helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: a novel and non-toxic mucosal adjuvant","volume":"36","author":"Holmgren","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0555","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.85.19.7109","article-title":"Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro","volume":"85","author":"Hardy","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0560","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pep.2010.04.021","article-title":"Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin a(2)\/B chimeras","volume":"74","author":"Tinker","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0565","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/CVI.05146-11","article-title":"Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin a(2)\/B chimera induces antigen-specific Th2-type responses in mice","volume":"18","author":"Arlian","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0570","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/toxins6041397","article-title":"Immunogenicity of a West Nile virus DIII-cholera toxin a(2)\/B chimera after intranasal delivery","volume":"6","author":"Tinker","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0575","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1016\/j.vaccine.2018.04.067","article-title":"Immunogenicity of a Staphylococcus aureus-cholera toxin a(2)\/B vaccine for bovine mastitis","volume":"36","author":"Misra","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0580","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/abio.2001.5084","article-title":"In vitro assembly of novel cholera toxin-like complexes","volume":"292","author":"Hatic","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0585","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pep.2016.03.007","article-title":"Purification and characterization of a novel cell-penetrating carrier similar to cholera toxin chimeric protein","volume":"129","author":"Lin","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0590","doi-asserted-by":"crossref","first-page":"34537","DOI":"10.18632\/oncotarget.5307","article-title":"Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit","volume":"6","author":"Lu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0595","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00253-013-5408-6","article-title":"Xing, immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB\/c mice model","volume":"98","author":"Guo","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0600","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/art.24566","article-title":"Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis","volume":"60","author":"Hasselberg","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1371\/journal.pone.0042434","article-title":"Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera","volume":"7","author":"Price","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0610","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.micres.2019.02.009","article-title":"Search for bacterial alpha 1,2-fucosyltransferasesfor whole-cell biosynthesis of 2 '-fucosyllactose in recombinant Escherichia coli","volume":"222","author":"Seydametova","year":"2019","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0615","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.sjbs.2018.08.019","article-title":"Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system","volume":"26","author":"Ibrahim","year":"2019","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0620","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2013.07.029","article-title":"Animal vaccines based on orally presented yeast recombinants","volume":"31","author":"Shin","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0625","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12257-008-0031-6","article-title":"Heterologous expression of cholera toxin B subunit in Saccharomyces cerevisiae","volume":"13","author":"Lim","year":"2008","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0630","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.vaccine.2011.11.059","article-title":"Merozoite surface protein-1 of plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice","volume":"30","author":"Miyata","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0635","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1016\/j.vaccine.2014.07.016","article-title":"Cholera toxin B subunit-five-stranded alpha-helical coiled-coil fusion protein: \u201cfive-to-five\u201d molecular chimera displays robust physicochemical stability","volume":"32","author":"Arakawa","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0640","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tifs.2016.09.006","article-title":"Nutrition, safety, market status quo appraisal of emerging functional food corn smut (huitlacoche)","volume":"57","author":"Patel","year":"2016","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133535","article-title":"The corn smut (\u2019Huitlacoche\u2019) as a new platform for oral vaccines","volume":"10","author":"Juarez-Montiel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0650","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pep.2009.10.002","article-title":"Rabies glycoprotein fused with B subunit of cholera toxin expressed in tobacco plants folds into biologically active pentameric protein","volume":"70","author":"Roy","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0655","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pep.2010.07.013","article-title":"Cholera toxin B subunit-domain III of dengue virus envelope glycoprotein E fusion protein production in transgenic plants","volume":"74","author":"Kim","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002046","article-title":"Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks","volume":"7","author":"Hamorsky","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0665","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pep.2016.06.006","article-title":"Expression and assembly of cholera toxin B subunit and domain III of dengue virus 2 envelope fusion protein in transgenic potatoes","volume":"139","author":"Kim","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2019.02.007","article-title":"Expression and active testing of VP7 from GCRV (grass carp reovirus) fused with cholera toxin B subunit in rice calli","volume":"158","author":"Zhang","year":"2019","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0675","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jbiotec.2008.03.002","article-title":"Expression of accessory colonization factor subunit A (ACFA) of Vibrio cholerae and ACFA fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum)","volume":"135","author":"Sharm","year":"2008","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.01.050_bb0680","first-page":"E429","article-title":"Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial, lancet","volume":"2","author":"Yuki","year":"2021","journal-title":"Microbe"},{"key":"10.1016\/j.jconrel.2022.01.050_bb0685","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cej.2020.127849","article-title":"Shape matters: morphologically biomimetic particles for improved drug delivery","volume":"410","author":"Wang","year":"2021","journal-title":"Chem. Eng. J."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:30:04Z","timestamp":1759163404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922000724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":137,"alternative-id":["S0168365922000724"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.050","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potential delivery system based on cholera toxin: A macromolecule carrier with multiple activities","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}